The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Pharmaceutical Quality Control Release Testing Service Market Across 2026–2030?
The pharmaceutical quality control release testing service market size has seen significant expansion in recent years. It is anticipated to increase from $7.55 billion in 2025 to $8.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market is attributable to more rigorous GMP regulations, a surge in worldwide drug production, the development of contract testing laboratories, a heightened need for biologics testing, and the broadening of generic drug manufacturing.
The pharmaceutical quality control release testing service market size is anticipated to experience substantial growth in the coming years. Its value is predicted to reach $11.01 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.9%. This expansion during the forecast period is primarily driven by factors such as the increasing number of complex biologic pipelines, a rise in the frequency of regulatory audits, the broadening of outsourced quality control models, the necessity for faster batch release cycles, and a surge in multi-region drug approvals. Prominent trends for this period are expected to include automated batch release testing, the adoption of digital laboratory quality systems, analytical validation assisted by AI, interconnected stability testing laboratories, and intelligent quality data platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33260&type=smp
What Primary Drivers Are Shaping The Development Of The Pharmaceutical Quality Control Release Testing Service Market?
The projected expansion of cell or gene therapy pipelines is set to fuel the growth of the pharmaceutical quality control release testing service market. A cell and gene therapy pipeline denotes cellular and genetic therapeutic products currently undergoing development and regulatory assessment for commercialization. This growth stems primarily from increased investment in biotechnology research and development, with pharmaceutical and biotech companies allocating significant resources towards pioneering cellular and genetic treatments for conditions previously lacking effective therapies. Consequently, the expanding cell and gene therapy pipeline directly amplifies the need for specialized quality control release testing services, which are critical to ensure these complex biological products comply with rigorous safety and efficacy standards prior to their market introduction. As an illustration, data released in January 2025 by the American Society of Gene and Cell Therapy, a US-based scientific association, showed the global gene therapy pipeline reached 2,117 programs in the fourth quarter of 2024, marking an increase from 2,041 programs in the third quarter of 2024. Ultimately, the increasing expansion of cell or gene therapy pipelines acts as a significant catalyst for the growth of the pharmaceutical quality control release testing service market.
What Segmentation Levels Are Considered In The Pharmaceutical Quality Control Release Testing Service Market?
The pharmaceutical quality control release testing service market covered in this report is segmented –
1) By Product Type: Dissolution Testing; Anti-Corrosion Testing; ICH Stability Storage and Testing; Other Product Types
2) By Service Type: Analytical Testing Services; Microbiological Testing Services; Stability Testing Services; Sterility Testing Services
3) By Technology: Gas Chromatography (GC); Mass Spectrometry; Spectroscopy Methods
4) By End Users: Pharmaceutical Manufacturers; Biotechnology Companies; Contract Development and Manufacturing Organizations (CDMOs); Contract Manufacturing Organizations (CMOs); Research and Academic Institutions
Subsegments:
1) By Dissolution Testing: Immediate Release Testing; Extended Release Testing; Delayed Release Testing; Sink Condition Evaluation
2) By Anti-Corrosion Testing: Packaging Material Corrosion Testing; Container Compatibility Assessment; Environmental Stress Corrosion Testing; Protective Coating Evaluation
3) By ICH Stability Storage and Testing: Long Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing
4) By Other Product Types: Impurity Profiling; Residual Solvent Testing; Elemental Impurity Analysis; Container Closure Integrity Testing
What Trends Are Projected To Affect The Pharmaceutical Quality Control Release Testing Service Market?
Major companies within the pharmaceutical quality control release testing services market are concentrating on developing advanced solutions, such as microbiological-based quality control testing, to ensure product sterility, regulatory compliance, and timely batch release. Microbiological-based quality control testing utilizes microbiological techniques to monitor and measure microbial presence in pharmaceutical products and production environments, which helps confirm sterility, maintain product safety, and meet regulatory requirements before batch release. For instance, in March 2025, Nelson Laboratories, a US-based microbiological testing company, introduced its Rapid Sterility Testing, a microbiology-based quality control testing offering aimed at modernizing sterility assurance processes. This solution is specifically designed to support faster batch release of sterile pharmaceutical products, shortening traditional fourteen-day incubation timelines to approximately six days, and incorporating automated, quantitative data analytics to enhance result precision, reduce manual intervention, and improve overall testing reliability.
Who Are The Top Companies Competing In The Pharmaceutical Quality Control Release Testing Service Market?
Major companies operating in the pharmaceutical quality control release testing service market are Labcorp Holdings Inc., SGS S.A., Eurofins Scientific SE, Selvita S.A., WuXi AppTec Co. Ltd., Intertek Group plc, Charles River Laboratories International Inc., Piramal Pharma Limited, Siegfried Holding AG, Almac Group Limited, NSF International, ClinChoice Inc., BioAgilytix Inc., Microbac Laboratories Inc., ARL Bio Pharma Inc., Quality Chemical Laboratories LLC, Neopharm Labs Inc., Butterworth Laboratories Limited, Cambridge Polymer Group Inc., Honeyman Group Limited, and Element Materials Technology Group Limited.
Read the full pharmaceutical quality control release testing service market report here:
How Does The Pharmaceutical Quality Control Release Testing Service Market Perform Across Major Global Regions?
North America was the largest region in the pharmaceutical quality control release testing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical quality control release testing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Quality Control Release Testing Service Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33260&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Quality Control Release Testing Service Market 2026, By The Business Research Company
Pharmaceutical Packaging Testing Equipment Market Report 2026
Pharma Admet Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report
Pharmaceutical Label Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model